It was a pleasure to talk to Maria Oliva-Hemker (Johns Hopkins University School of Medicine, Baltimore, MD, US) around her presentation on ‘Treatment Updates: Where Do Immunomodulators Fit in Current Approaches to Therapy?’ which was presented at the virtual 2021 Crohn’s & Colitis Congress.
Questions
- What has clinical data taught us about the role of immunomodulator monotherapy for induction and maintenance of remission in paediatric IBD therapy? (0:15)
- At what stage would you advise a step up to anti-TNF therapy? (4:22)
- When should we use immunotherapy in combination with anti-TNFs agents? (5:31)
Disclosures: Maria Oliva-Hemker has nothing to disclose in relation to this video.
Support: Interview and filming supported by Touch Medical Media.
Filmed as a highlight of CCC 2021 (Virtual).
